Latest filing: Dr. Agarwals Health Care Ltd - 544350 - Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
ObservedCompany dossier
Dr. Agarwal's Health Care
NSE:AGARWALEYE · ISIN INE943P01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Dr. Agarwal's Health Care
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹430.7 Cr · PAT ₹28.2 Cr.
Exchange XBRLLatest ownership: promoter group 32.34% and public 67.66% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Dr. Agarwals Health Care Ltd - 544350 - Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
BSE · financial results
Observed
Source filing Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
BSE · exchange filing
Observed
Source filing Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE · investor presentation
Observed
Source filing Dr. Agarwals Health Care Ltd - 544350 - Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹430.7 Cr
- Profit after tax
- ₹28.2 Cr
- EPS
- ₹0.73
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 32.34%
- Public
- 67.66%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL